Aliases & Classifications for Lymphocele

MalaCards integrated aliases for Lymphocele:

Name: Lymphocele 12 44 15 73
Lymphocele Adverse Event 73
Lymph Cyst 12

Classifications:



External Ids:

Disease Ontology 12 DOID:4347
MeSH 44 D008210
NCIt 50 C78442

Summaries for Lymphocele

MalaCards based summary : Lymphocele, also known as lymphocele adverse event, is related to campomelia, cumming type and cervicitis. An important gene associated with Lymphocele is KLK3 (Kallikrein Related Peptidase 3), and among its related pathways/superpathways are Immune response Function of MEF2 in T lymphocytes and Transcription Androgen Receptor nuclear signaling. The drugs Basiliximab and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include kidney, lymph node and prostate.

Wikipedia : 76 A lymphocele is a collection of lymphatic fluid within the body not bordered by epithelial lining. It is... more...

Related Diseases for Lymphocele

Graphical network of the top 20 diseases related to Lymphocele:



Diseases related to Lymphocele

Symptoms & Phenotypes for Lymphocele

Drugs & Therapeutics for Lymphocele

Drugs for Lymphocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 82)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Basiliximab Approved, Investigational Phase 4,Phase 3 152923-56-3, 179045-86-4
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3 22916-47-8 4189
3
Triamcinolone Approved, Vet_approved Phase 4,Phase 3 124-94-7 31307
4
Prednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 50-24-8 5755
5
Everolimus Approved Phase 4,Phase 3 159351-69-6 6442177
6
Tacrolimus Approved, Investigational Phase 4,Phase 2,Phase 3 104987-11-3 445643 439492
7
Mycophenolic acid Approved Phase 4,Phase 2,Phase 3 24280-93-1 446541
8
Benzocaine Approved, Investigational Phase 4 1994-09-7, 94-09-7 2337
9
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 2,Phase 3 128794-94-5 5281078
10
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2,Phase 3 83-43-2 6741
11
Sirolimus Approved, Investigational Phase 4,Phase 3 53123-88-9 5284616 6436030 46835353
12
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
13
Heparin Approved, Investigational Phase 4 9005-49-6 772 46507594
14 tannic acid Approved, Nutraceutical Phase 4
15 Hemostatics Phase 4,Phase 3,Not Applicable
16 triamcinolone acetonide Phase 4,Phase 3
17 Prednisolone acetate Phase 4,Phase 2,Phase 3
18 glucocorticoids Phase 4,Phase 2,Phase 3
19 Fibrinolytic Agents Phase 4,Not Applicable
20 Methylprednisolone acetate Phase 4,Phase 2,Phase 3
21 Methylprednisolone Hemisuccinate Phase 4,Phase 2,Phase 3
22 Gastrointestinal Agents Phase 4,Phase 2,Phase 3
23 Coagulants Phase 4,Phase 3,Not Applicable
24 Neuroprotective Agents Phase 4,Phase 2,Phase 3
25 Cyclosporins Phase 4,Phase 3
26 Anesthetics Phase 4
27 Hormone Antagonists Phase 4,Phase 3,Phase 2
28 Dermatologic Agents Phase 4,Phase 3
29 Triamcinolone diacetate Phase 4,Phase 3
30 Triamcinolone hexacetonide Phase 4,Phase 3
31 Hormones Phase 4,Phase 3,Phase 2
32 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2
33 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3
34 Anti-Bacterial Agents Phase 4,Phase 2,Phase 3,Not Applicable
35 Antibiotics, Antitubercular Phase 4,Phase 2,Phase 3,Not Applicable
36 Immunoglobulin G Phase 4
37 Antibodies Phase 4
38 Immunoglobulins Phase 4
39 Anticoagulants Phase 4,Not Applicable
40 Immunosuppressive Agents Phase 4,Phase 2,Phase 3,Not Applicable
41 Prednisolone hemisuccinate Phase 4,Phase 2,Phase 3
42 Prednisolone phosphate Phase 4,Phase 2,Phase 3
43 Anti-Infective Agents Phase 4,Phase 2,Phase 3
44 Antiemetics Phase 4,Phase 2,Phase 3
45 Antifungal Agents Phase 4,Phase 3
46 Protective Agents Phase 4,Phase 2,Phase 3
47 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3
48 Antilymphocyte Serum Phase 4
49 Antitubercular Agents Phase 4,Phase 2,Phase 3
50 Antirheumatic Agents Phase 4,Phase 3

Interventional clinical trials:

(show all 46)
# Name Status NCT ID Phase Drugs
1 A Study for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection Completed NCT02476357 Phase 4
2 Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer. Completed NCT02001857 Phase 4 1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.
3 Clinical Trial of a Silver Eluting Dressing System Completed NCT01229358 Phase 4
4 Improved Induction and Maintenance Immunosuppression in Kidney Transplantation Completed NCT00556933 Phase 4 rabbit anti-thymocyte globulin;mycophenolate mofetil;rabbit anti-thymocyte globulin;sirolimus;tacrolimus
5 Calcineurin Inhibitor Avoidance With Thymoglobulin and Sirolimus in Kidney Transplantation Completed NCT00305396 Phase 4 Sirolimus
6 SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus Completed NCT00371826 Phase 4 Everolimus (RAD001);Cyclosporine (Calcineurin Inhibitor (CNI));Methylprednisone/prednisone;Mycophenolate sodium (MPA)
7 MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant Patients Completed NCT00231764 Phase 4 daclizumab
8 PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Recruiting NCT03006562 Phase 4 Subcutaneous Heparin
9 Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporineversus an Immunosuppressive Regimen With Mycophenolic Acid and Active, not recruiting NCT02328963 Phase 4 Everolimus;mycophenolic acid
10 Prospective Randomized Trial Comparing Robotic Versus Open Radical Prostatectomy Terminated NCT01365143 Phase 4
11 Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer Unknown status NCT01974193 Phase 3 Floseal
12 Tachosil for the Prevention of Symptomatic Lymph Cysts Completed NCT01470677 Phase 3 Tachosil fibrin patch
13 Prevention of Lymphorrhea by Lanreotide in Axillary Dissection for Breast Cancer Completed NCT00630695 Phase 3 Lanreotide LP 90;Placebo lanreotide
14 Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplantation Completed NCT01631448 Phase 3
15 Myfortic vs. Cellcept in Kidney Transplant Recipients Completed NCT00533624 Phase 2, Phase 3 Mycophenolate Sodium Delayed Release Tablets;Mycophenolate Mofetil
16 12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients Completed NCT01843348 Phase 3 Everolimus;Tacrolimus;Cyclosporin A;Enteric Coated Mycophenolate Sodium (EC-MPS);Mycophenolate mofetil (MMF);Corticosteroids;Simulect
17 A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer Recruiting NCT03071289 Phase 3 Cisplatin
18 Surgical Complications Related to Primary or Interval Debulking in Ovarian Neoplasm Active, not recruiting NCT01461850 Phase 3 Neoadjuvant chemotherapy + Interval Debulking Surgery
19 Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer Completed NCT01356862 Phase 2 PASIREOTIDE;PLACEBO
20 Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer Recruiting NCT02125513 Phase 2 carboplatin and paclitaxel followed by surgery
21 Tolerance by Engaging Antigen During Cellular Homeostasis Not yet recruiting NCT03504241 Phase 1 alemtuzumab;belatacept;sirolimus;mycophenolate mofetil;mycophenolate acid;prednisone
22 Thunderbeat Technology vs Standard Bipolar Electro-surgery in Total Laparoscopic Hysterectomy With Pelvic Lymphadenectomy for Endometrial Cancer Unknown status NCT01717794 Not Applicable
23 Lymphedema After Primary Surgery for Endometrial Cancer Unknown status NCT02115477
24 Thunderbeat Technology vs Standard Bipolar Electro Surgery in Laparoscopic Radical Hysterectomy and Pelvic Lymphadenectomy for Cervical Cancer Unknown status NCT01717781 Not Applicable
25 Cold Plasma for the Reduction of Lymphoceles Following PLND Completed NCT02658851 Not Applicable
26 Prevention of Lymphoceles After Robotic PLND Completed NCT02035475 Not Applicable
27 Prophylactic Fenestration of the Peritoneum in Kidney Transplantation Completed NCT01206868 Not Applicable
28 Efficacy Study of FloSeal for Prevention of Lymphocele After Lymphadenectomy for Gynecologic Cancer Completed NCT01679483 Not Applicable FloSeal application
29 Efficacy Study of Ifabond in Breast Cancer Surgery Completed NCT01742975 Not Applicable
30 The Comparison of Conventional and Advanced Bipolar Energy Modalities During Laparoscopic Staging Surgery of Gynecologic Cancers Completed NCT02822820 Not Applicable
31 Fibrin Sealant in Renal Transplantation Completed NCT00910052 Not Applicable
32 2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial Completed NCT02320578 Not Applicable
33 2D Versus 3D Radical Laparoscopic Hysterectomy for Endometrial Cancer: a Prospective Randomized Trial Completed NCT02320565 Not Applicable
34 Radiofrequency Ablation vs Conventional Surgery for Superficial Venous Insufficiency Completed NCT02588911 Not Applicable
35 Management of Symptomatic Post-operative Lymphocele Recruiting NCT02800980
36 PREvention of Post-mastectomy LYMphoceles by PAdding Recruiting NCT02894021 Not Applicable
37 Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers Recruiting NCT02986568 Not Applicable Cisplatin;Cisplatin;5-fluorouracil, Cisplatin;5-fluorouracil, Cisplatin;Doxorubicin, Cisplatin
38 Dead Space Closure With Quilting Suture Versus Conventional Closure With Drainage Recruiting NCT02263651 Not Applicable
39 Sentinel Lymph Node Detection in Endometrial Cancer Recruiting NCT02690259 Not Applicable
40 ADNEXMR Scoring System: Impact of an MR Scoring System on Therapeutic Strategy of Pelvic Adnexal Masses Recruiting NCT02664597 Not Applicable
41 Sentinel Lymph Node Biopsy in Patients With Early Stages Cervical Cancer Recruiting NCT02494063
42 Use of the Sentinel Node Biopsy for Early Endometrial Cancer. Recruiting NCT02545348
43 Open Anterograde Radical Prostatectomy Compared to Open Retrograde Technique Recruiting NCT02687308 Not Applicable
44 Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy Not yet recruiting NCT03567525 Not Applicable
45 Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer Suspended NCT02834988 Not Applicable
46 Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer Terminated NCT01644136 Not Applicable

Search NIH Clinical Center for Lymphocele

Cochrane evidence based reviews: lymphocele

Genetic Tests for Lymphocele

Anatomical Context for Lymphocele

MalaCards organs/tissues related to Lymphocele:

41
Kidney, Lymph Node, Prostate, Liver, Breast, Pancreas, Testis

Publications for Lymphocele

Articles related to Lymphocele:

(show top 50) (show all 337)
# Title Authors Year
1
Treatment of refractory groin lymphocele by surrounding supermicrosurgical lymphaticovenous anastomosis. ( 29788678 )
2018
2
Prospective Randomized Controlled Trial Exploring the Effect of TachoSil on Lymphocele Formation After Extended Pelvic Lymph Node Dissection in Prostate Cancer. ( 29775698 )
2018
3
Robotic prostatectomy leading to a delayed MRSA infected lymphocele: a case report and review of the literature. ( 29344094 )
2018
4
An unusual localization of seven months delayed pelvic lymphocele following radical retropubic prostatectomy: Case report and literature review. ( 29524857 )
2018
5
Functional significance and risk factors for lymphocele formation after renal transplantation. ( 29864262 )
2018
6
Transinguinal interstitial (intranodal) lymphatic embolization to treat high-output postoperative lymphocele. ( 29551619 )
2018
7
Doxycycline sclerotherapy for post-traumatic inguinal lymphocele in a child. ( 29367372 )
2018
8
Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery. ( 29599346 )
2018
9
Regarding "Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients". ( 29579476 )
2018
10
Comparison Between Bipolar Lymphatic Vessels Cautery and Suture Ligature in Prevention of Postrenal Transplant Lymphocele Formation: A Randomized Controlled Trial. ( 29697354 )
2018
11
TEMPORARY REMOVAL: P.L.E.A.T. - Preventing Lymphocele Ensuring Absorption Transperitoneally: a novel robotic technique. ( 28554519 )
2017
12
Microbiological evaluation of infected pelvic lymphocele after robotic prostatectomy: potential predictors for culture positivity and selection of the best empirical antimicrobial therapy. ( 28439680 )
2017
13
Delayed Infection of a Lymphocele following RARP in a Patient with Nonspecific Symptoms. ( 28396817 )
2017
14
Rate of Symptomatic Lymphocele Formation After Extraperitoneal vs Transperitoneal Robot-Assisted Radical Prostatectomy and Bilateral Pelvic Lymphadenectomy. ( 28741376 )
2017
15
Nomogram predicting risk of lymphocele in gynecologic cancer patients undergoing pelvic lymph node dissection. ( 28989920 )
2017
16
Treatment of Post-transplant Lymphocele in Children. ( 28132852 )
2017
17
Lymphocele Following Liposuction in the Thigh. ( 28664307 )
2017
18
Reply from Authors re: Jens Uwe Stolzenburg, Iason Kyriazis, Evangelos Liatsikos. Postoperative Lymphocele Formation after Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Should Not Be Considered an Inevitable Consequence of the Approach. Eur Urol 2017;71:159-60: Which Lymphatic Vessels Have To Be Secured During Pelvic Lymph Node Dissection for Prostate Cancer? ( 27666998 )
2017
19
Lymphocele infection due to Peptoniphilus harei after radical prostatectomy. ( 29153289 )
2017
20
Evaluation of sclerotherapy for the treatment of infected postoperative lymphocele. ( 28805604 )
2017
21
Lymphocele after Lipoma Removal in Inner Thigh. ( 28223756 )
2017
22
A Breast Reconstruction Using a Breast Prosthesis and Capsular Flap for a Lymphocele Patient. ( 29184742 )
2017
23
Prevention of lymphocele by using gelatin-thrombin matrix as a tissue sealant after pelvic lymphadenectomy in patients with gynecologic cancers: a prospective randomized controlled study. ( 28382800 )
2017
24
A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection. ( 29484065 )
2017
25
Critical appraisal of consecutive 36 cases of post renal transplant lymphocele: a proposed algorithm. ( 28138768 )
2017
26
Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients. ( 28822659 )
2017
27
Modern lymphatic dissection techniques for preventing post renal transplant lymphocele. ( 29151791 )
2017
28
Prophylaxis of lymphocele formation after kidney transplantation via peritoneal fenestration: aA systematic review. ( 28295643 )
2017
29
Treatment of the Lymphocele After Kidney Transplantation: A Single-center Experience. ( 27496462 )
2016
30
Use of TachoSilAr to Prevent Symptomatic Lymphocele after an Aggressive Tumor Debulking with Lymphadenectomy for Advanced Stage Ovarian Cancer. A Pilot Study. ( 27046053 )
2016
31
Prevention and management of lymphocele formation following kidney transplantation. ( 28011070 )
2016
32
Single-Session Endolymphatic Glue Embolization of Lymphocele after Heart Transplantation. ( 27287975 )
2016
33
Postoperative Lymphocele Formation after Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy Should Not Be Considered an Inevitable Consequence of the Approach. ( 27595375 )
2016
34
Symptomatic Lymphocele Formation After Sentinel Lymph NodeA Biopsy for Early Stage Cervical Cancer. ( 26260297 )
2016
35
The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection. ( 26800257 )
2016
36
Evaluation of postoperative lymphocele according to amounts and symptoms by using 3-dimensional CT volumetry in kidney transplant recipients. ( 27617254 )
2016
37
Massive Ascites in a Renal Transplant Patient after Laparoscopic Fenestration of a Lymphocele. ( 27891288 )
2016
38
Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study. ( 27280398 )
2016
39
Delayed lymphocele formation following lateral lumbar interbody fusion of the spine. ( 27349755 )
2016
40
Prospective Randomized Study to Compare Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Therapeutic Lymph Node Dissection With or Without the Use of an Ultrasonic Scalpel. ( 26714939 )
2016
41
Urinary obstruction from lymphocele. ( 25549131 )
2015
42
Abdominal Wall Lymphocele Following Gynecologic Surgery: A Case Report and Literature Review. ( 27679097 )
2015
43
Lymphocele: a clinical analysis of 19 cases. ( 26221274 )
2015
44
Does ultrasonic advanced energy reduce lymphocele incidence in laparoscopic para-aortic lymphadenectomy? ( 25528730 )
2015
45
Delayed complication of pelvic lymphocele: Ileal conduit obstruction. ( 26166973 )
2015
46
The Use of Haemostatic Agents and Sealants for the Prevention of Lymphocele After Urological Surgery: A Review of the Literature. ( 26680378 )
2015
47
Successful Treatment of Massive Pulmonary Embolism With Catheter-Directed Thrombolysis in a Patient With Lymphocele: A Rare Cause of Thromboembolism. ( 26381364 )
2015
48
Supramicrosurgical lymphatic-venous anastomosis for postsurgical subcutaneous lymphocele treatment. ( 26314286 )
2015
49
Awake tracheal intubation with combined use of King Visiona8c videolaryngoscope and a fiberoptic bronchoscope in a patient with giant lymphocele. ( 25669006 )
2014
50
Lymphocele after pediatric kidney transplantation: incidence and risk factors. ( 25163815 )
2014

Variations for Lymphocele

Expression for Lymphocele

Search GEO for disease gene expression data for Lymphocele.

Pathways for Lymphocele

Pathways related to Lymphocele according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.1 CABIN1 MTOR
2
Show member pathways
10.79 KLK3 MTOR

GO Terms for Lymphocele

Biological processes related to Lymphocele according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 multicellular organism growth GO:0035264 8.62 ANKRD11 MTOR

Sources for Lymphocele

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....